Vanguard Group
DWTX

Vanguard Group’s Dogwood Therapeutics DWTX Stock Holding History

Vanguard Group’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$125K Buy
29,955
+7,776
+35% +$45.8K ﹤0.01% 4152
2025
Q3 		$171K Buy
22,179
+10,397
+88% +$51.7K ﹤0.01% 4153
2025
Q2 		$56.9K Hold
11,782
– – ﹤0.01% 4188
2025
Q1 		$59K Buy
+11,782
New +$79.8K ﹤0.01% 4178
2024
Q4 		– Sell
-8,355
Closed -$35.5K – 4329
2024
Q3 		$35.5K Hold
8,355
– – ﹤0.01% 4268
2024
Q2 		$44.9K Hold
8,355
– – ﹤0.01% 4300
2024
Q1 		$100K Hold
8,355
– – ﹤0.01% 4242
2023
Q4 		$120K Hold
8,355
– – ﹤0.01% 4280
2023
Q3 		$193K Sell
8,355
-85
-1% -$2.96K ﹤0.01% 4255
2023
Q2 		$291K Buy
8,440
+7,608
+914% +$217K ﹤0.01% 4241
2023
Q1 		$7.64K Sell
832
-5,114
-86% -$40.7K ﹤0.01% 4543
2022
Q4 		$35.1K Sell
5,946
-3,721
-38% -$28K ﹤0.01% 4468
2022
Q3 		$92K Hold
9,667
– – ﹤0.01% 4502
2022
Q2 		$1.02M Hold
9,667
– – ﹤0.01% 4079
2022
Q1 		$1.08M Buy
9,667
+3,752
+63% +$546K ﹤0.01% 4178
2021
Q4 		$757K Hold
5,915
– – ﹤0.01% 4340
2021
Q3 		$782K Buy
5,915
+275
+5% +$38K ﹤0.01% 4296
2021
Q2 		$887K Buy
+5,640
New +$800K ﹤0.01% 4174

Other funds holding DWTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Vanguard Group's DWTX Position: Q4 2025 in Review

Vanguard Group increased its Dogwood Therapeutics (DWTX) stake by 35% in Q4 2025, buying an estimated $45.8K and bringing the position to 29,955 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #4152.

Vanguard Group first reported a position in DWTX in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.08M in Q1 2022. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2025.

  • Vanguard Group held 29,955 shares of Dogwood Therapeutics worth $125K as of Q4 2025.
  • Vanguard Group bought 7,776 Dogwood Therapeutics shares in Q4 2025, an estimated $45.8K.
  • Dogwood Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4152 holding.
  • Vanguard Group first reported a position in Dogwood Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Vanguard Group's Dogwood Therapeutics position peaked at $1.08M in Q1 2022.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.